Comparative Effectiveness of an Artificial Air Pocket Device to Delay Asphyxiation in Supine Individuals Critically Buried in Avalanche Debris.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 05 2023
Historique:
medline: 17 5 2023
pubmed: 15 5 2023
entrez: 15 5 2023
Statut: epublish

Résumé

Approximately 70% of individuals critically buried in avalanche debris die within 35 minutes as a result of asphyxial cardiac arrest. An artificial air-pocket device (AAPD) that separates inhaled air from exhaled air may delay the onset of severe hypoxemia and eventual asphyxia during snow burial. To investigate the efficacy of a new AAPD during snow burial in a supine position. This comparative effectiveness trial was performed in winter 2016 with data analysis in November 2016 and November 2022. Each trial used a simulated critical avalanche burial scenario, in which a trough was dug in a snow pile and an additional air pocket of 0.5 L volume was punched into the lateral wall for each control trial. All participants were buried in a supine position. Trials could be voluntarily terminated at any time, with a maximum length of 60 minutes; trials were automatically terminated if the participant's peripheral oxygen saturation (Spo2) dropped to less than 84%. Each participant conducted 2 trials, one in which they breathed into the AAPD (intervention trial) and the other in which they breathed into the prepared air pocket (control trial). Measurements included Spo2, cerebral oxygenation, ventilatory parameters, respiratory gas concentrations, and visual-analogue scales. Kaplan-Meier survival curves and rank test for matched survival data were used to analyze the total burial time in each trial. A total of 13 volunteers (9 men; mean [SD] age, 33 [8] years) were exposed to the intervention and control trials. Intervention trials were terminated less often (2 of 13 trials) as a result of hypoxemia than control trials (11 of 12 trials). Similarly, survival curves showed a longer duration of burial in the intervention compared with the control trials for the time to reach an Spo2 less than 84% (rank test for matched survival data: P = .003). The intervention trials, compared with the control trials, also had slower rates of decrease in fraction of inspired oxygen (mean [SD] rate, -0.8 [0.4] %/min vs -2.2 [1.2] %/min) and of increase in fraction of inspired carbon dioxide (mean [SD] rate, 0.5 [0.3] %/min vs 1.4 [0.6] %/min) and expired ventilation per minute (mean [SD] rate, 0.5 [1.0] L/min2 vs 3.9 [2.6] L/min2). This comparative effectiveness trial found that the new AAPD was associated with delaying the development of hypoxemia and hypercapnia in supine participants in a critical burial scenario. Use of the AAPD may allow a longer burial time before asphyxial cardiac arrest, which might allow longer times for successful rescue by companions or by prehospital emergency medical services.

Identifiants

pubmed: 37184835
pii: 2804868
doi: 10.1001/jamanetworkopen.2023.13376
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2313376

Auteurs

Giacomo Strapazzon (G)

Institute of Mountain Emergency Medicine, Eurac Research, Bolzano, Italy.
Corpo Nazionale Soccorso Alpino e Speleologico, Milano, Italy.

Simon Rauch (S)

Institute of Mountain Emergency Medicine, Eurac Research, Bolzano, Italy.
Department of Anesthesia and Intensive Care Medicine, F. Tappeiner Hospital, Merano, Italy.

Sandro Malacrida (S)

Institute of Mountain Emergency Medicine, Eurac Research, Bolzano, Italy.

Tomas Dal Cappello (T)

Institute of Mountain Emergency Medicine, Eurac Research, Bolzano, Italy.

Enrica Governo (E)

Mountain Medicine Center, Azienda Sanitaria Valle d'Aosta, Aosta, Italy.

Bruna Catuzzo (B)

Mountain Medicine Center, Azienda Sanitaria Valle d'Aosta, Aosta, Italy.

Simona Mrakic-Sposta (S)

Institute of Clinical Physiology, National Research Council, Milano, Italy.

Margherita Urgesi (M)

Mountain Medicine Center, Azienda Sanitaria Valle d'Aosta, Aosta, Italy.

Marika Falla (M)

Institute of Mountain Emergency Medicine, Eurac Research, Bolzano, Italy.
Center for Mind/Brain Sciences, University of Trento, Rovereto, Italy.

Gianluca Cavoretto (G)

Mountain Medicine Center, Azienda Sanitaria Valle d'Aosta, Aosta, Italy.

Enrico Visetti (E)

Mountain Medicine Center, Azienda Sanitaria Valle d'Aosta, Aosta, Italy.
Department of Anesthesia and Intensive Care, Gruppo Policlinico di Monza, Monza, Italy.

Guido Giardini (G)

Mountain Medicine Center, Azienda Sanitaria Valle d'Aosta, Aosta, Italy.

Hermann Brugger (H)

Institute of Mountain Emergency Medicine, Eurac Research, Bolzano, Italy.

Federico Prato (F)

Corpo Nazionale Soccorso Alpino e Speleologico, Milano, Italy.
Mountain Medicine Center, Azienda Sanitaria Valle d'Aosta, Aosta, Italy.
Department of Emergency Medicine, Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH